Pharma Focus Asia
KP - Sustainable Packaging Solutions

Japan-based Takeda Pharmaceutical invests $25m in drug discovery firm BioMotiv


BioMotiv and Takeda Pharmaceutical Company has entered into Strategic Partnership,where Takeda has made a initial investment of $25million in BioMotiv.


This partnership will leverage the strengths of both organizations to identify and develop pioneering medical innovations.

The $25 million investment includes exclusive rights relating to programs sourced by BioMotiv specifically in the therapeutic areas of Immunology & Inflammation and Cardio-metabolic Diseases.

Specifications Table:

  • Company Name
  • Takeda Pharmaceutical
  • Company Invested In
  • BioMotiv
  • Location
  • Cleveland, Ohio
  • Date of Completion
  • 2019
  • Estimated Cost
  • $25 million
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?